Screening for glaucoma using GDx-VCC in a population with ≥1 risk factors

Canadian Journal of Ophthalmology

Volumn 48, Issue 4, 2013, Pages 279-285

  Li, Gisèle ^a   Fansi, Alvine Kamdeu ^a   Harasymowycz, Paul ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GDX VCC; GLAUCOMA; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGY; PERIMETRY; PREDICTIVE VALUE; RETINAL NERVE FIBER LAYER THICKNESS; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 84888358134     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2013.03.012     Document Type: Article

References (37)

1. Buhrmann R, Hodge W, Beardmore J, et al. Foundations for a Canadian Vision Health Strategy. National Coalition for Vision Health. 2007. Available at: www.visionhealth.ca/ncvh-projects.htm. Accessed October 31, 2012.
2. Mowatt G, Burr JM, Cook JA, et al. Screening tests for detecting open-angle glaucoma: systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2008;49: 5373-85.
3. Maul EA, Jampel HD. Glaucoma screening in the real world. Ophthalmology. 2010;117: 1665-6.
4. Tóth M, Kóthy P, Vargha P, Holló G. Accuracy of combined GDx-VCC and matrix FDT in a glaucoma screening trial. J Glaucoma. 2007;16: 462-70.
5. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthal-mol. 2002;86: 238-42.
6. Saito H, Tsutsumi T, Araie M, Tomidokoro A, Iwase A. Sensitivity and specificity of the Heidelberg Retina Tomograph II Version 3.0 in a population-based study: the Tajimi Study. Ophthalmology. 2009;116: 1854-61.
7. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care, 1994. Available at: www.phac-aspc.gc.ca/publicat/clinic-clinique/index. html. Accessed January 10, 2010.
8. Fleming C, Whitlock EP, Beil T, Smit B, Harris RP. Screening for primary open-angle glaucoma in the primary care setting: an update for the US Preventive Services Task Force. Ann Fam Med. 2005;3: 167-70.
9. Friedman DS, Freeman E, Munoz B, Jampel HD, West SK. Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007;114: 2232-7.
10. Freeman EE, Muñoz B, West SK, Jampel HD, Friedman DS. Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology. 2008;115: 233-8.
11. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucom-atous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115: 777-84.
12. McGwin G Jr, Xie A, Mays A, et al. Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci. 2005;46: 4437-41.
13. Sherwood MB, Garcia-Siekavizza A, Meltzer MI, Hebert A, Burns AF, McGorray S. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 1998;105: 561-6.
14. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111: 1439-48.
15. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109: 1090-5.
16. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994;112: 69-73.
17. Nemesure B, Leske MC, He Q, Mendell N. Analyses of reported family history of glaucoma: a preliminary investigation. The Barbados Eye Study Group. Ophthalmic Epidemiol. 1996;3: 135-41.
18. Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol. 1998;116: 1640-5.
19. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Family Practice. 2004;21: 4-10.
20. Bayer A, Harasymowycz P, Henderer JD, Steinmann WG, Spaeth GL. Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage. Am J Ophthalmol. 2002;133: 758-63.
21. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129: 314-22.
22. Gardiner SK, Anderson DR, Fingeret M, McSoley JJ, Johnson CA. Evaluation of decision rules for frequency-doubling technology screening tests. Optom Vis Sci. 2006;83: 432-7.
23. Spry PG, Bates AB, Johnson CA, Chauhan BC. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41: 2192-200.
24. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107: 1809-15.
25. Weinreb RN, Dreher AW, Coleman A, Quigley H, Shaw B, Reiter K. Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol. 1990;108: 557-60.
26. Vapnik VN. Statistical Learning Theory. Toronto: Wiley; 1998.
27. Healey PR, Lee AJ, Aung T, Wong TY, Mitchell P. Diagnostic accuracy of the Heidelberg Retina Tomograph for glaucoma a population-based assessment. Ophthalmology. 2010;117: 1667-73.
28. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. New Engl J Med. 1978;299: 926-30.
29. Reus NJ, Lemij HG. Diagnostic accuracy of the GDx VCC for glaucoma. Ophthalmology. 2004;111: 1860-5.
30. Oddone F, Centofanti M, Tanga L, et al. Influence of disc size on optic nerve head versus retinal nerve fiber layer assessment for diagnosing glaucoma. Ophthalmology. 2011;118: 1340-7.
31. Kondo Y, Yamamoto T, Sato Y, Matsubara M, Kitazawa Y. A frequency-doubling perimetric study in normal-tension glaucoma with hemifield defect. J Glaucoma. 1998;7: 261-5.
32. Bayer AU, Erb C. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects. Ophthalmology. 2002;109: 1009-17.
33. Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol. 2004;137: 863-71.
34. Medeiros FA, Zangwill LM, Bowd C, Sample PA, Weinreb RN. Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci. 2006;47: 1008-15.
35. Levy NS, Schachar IH. Accuracy of GDx variable corneal compensation polarization measurements in normal human eyes: effects of accommodation, cycloplegia, focus, pupil size, and eye selection on reproducibility. Eye. 2007;21: 333-40.
36. Harasymowycz PJ, Papamatheakis DG, Fansi AK, et al. Validity of screening for glaucomatous optic nerve damage using confocal scanning laser ophthalmoscopy (Heidelberg Retina Tomograph II) in high-risk populations: a pilot study. Ophthalmology. 2005;112: 2164-2171.
37. Anraku A, Jin YP, Butty Z, et al. The Toronto epidemiology glaucoma survey: a pilot study. Can J Ophthalmol. 2011;46: 352-7.